Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
110.1 USD | +0.29% | +2.45% | +75.83% |
05-30 | Transcript : Natera, Inc. Presents at 2024 Leerink Partners Healthcare Crossroads Conference, May-30-2024 10:40 AM | |
05-23 | U.S. FDA advisers back approval for Guardant's cancer test | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+75.83% | 13.52B | |
+23.80% | 87.77B | |
-29.03% | 70.35B | |
-5.56% | 25.03B | |
+3.42% | 17.73B | |
-14.89% | 16.31B | |
+1.05% | 15.48B | |
+40.45% | 12.9B | |
+76.22% | 13.01B | |
-3.27% | 12.06B |
- Stock Market
- Equities
- NTRA Stock
- News Natera, Inc.
- Piper Sandler Adjusts Price Target on Natera to $120 From $110, Maintains Overweight Rating